Набор от данни:  Актуализация на регистрите на НСЦРЛП към 02.06.2019 г.

одобрен

Приложение 4 на ПЛС от 02.06.2019 г.

Уникален идентификатор:  f09a5d85-659a-4b8f-bb62-2e369d2147cb

Текуща версия: 1

Показвана версия: 1

Формат: CSV

  • Създаден на: 2019-06-04 09:40:33
  • Създаден от: georgi_sivchev
  • Последна промяна: 2019-06-04 09:40:33
записа на страница
Подреди по:
Възходящ ред Низходящ ред

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Atorvastatin 20100640 Avanor, Film coated tablet, 10, mg, Pack: 30 Тева Фармасютикълс България ЕООД, България Teva Pharma S.L.U., Spain; TEVA Pharmaceutical Works Private Limited Company, Debrecen Hungary; TEVA Pharmaceutical Works Private Limited Company, Gödöllö Hungary; Teva Czech Industries s.r.o., Czech Republic; Pharmachemie B.V., the Netherlands; Teva UK, UK; TEVA Sante, France; Teva Operations Poland; Merckle Gmbh, Germany 1.84 0.37 2.21 7% 0.13 1.97 0.39 2.36 20% 0.37 2.34 0.47 2.81 Протокол № 234/20.07.2017 НСР-3697/06.06.2014 23.06.2014 02.08.2017 Неактивен 2906
Atorvastatin 20100641 Avanor, Film coated tablet, 10, mg, Pack: 30 Тева Фармасютикълс България ЕООД, България Teva Pharma S.L.U., Spain; TEVA Pharmaceutical Works Private Limited Company, Debrecen Hungary; TEVA Pharmaceutical Works Private Limited Company, Gödöllö Hungary; Teva Czech Industries s.r.o., Czech Republic; Pharmachemie B.V., the Netherlands; Teva UK, UK; TEVA Sante, France; Teva Operations Poland; Merckle Gmbh, Germany 1.84 0.37 2.21 7% 0.13 1.97 0.39 2.36 20% 0.37 2.34 0.47 2.81 НСР-3697/06.06.2014 23.06.2014 23.06.2014 Неактивен 2906
Atorvastatin 20100640 Avanor, Film coated tablet, 20, mg, Pack: 30 Тева Фармасютикълс България ЕООД, България Teva Pharma S.L.U., Spain; Teva UK, UK; Teva Operations Poland; Merckle Gmbh, Germany 1.88 0.38 2.26 7% 0.13 2.01 0.4 2.41 20% 0.38 2.39 0.48 2.87 промяна на обстоятелства НСР-12679/12.05.2017 НСР-5961/01.04.2015. 16.04.2015 02.06.2017 Неактивен 964
Atorvastatin 20100640 Avanor, Film coated tablet, 20, mg, Pack: 30 Тева Фармасютикълс България ЕООД, България Teva Pharma S.L.U., Spain; TEVA Pharmaceutical Works Private Limited Company, Debrecen Hungary; TEVA Pharmaceutical Works Private Limited Company, Gödöllö Hungary; Teva Czech Industries s.r.o., Czech Republic; Pharmachemie B.V., the Netherlands; Teva UK, UK; TEVA Sante, France; Teva Operations Poland; Merckle Gmbh, Germany 1.88 0.38 2.26 7% 0.13 2.01 0.4 2.41 20% 0.38 2.39 0.48 2.87 НСР-5961/01.04.2015. 16.04.2015 16.04.2015 Неактивен 964
Atorvastatin 20100640 Avanor, Film coated tablet, 20, mg, Pack: 30 Тева Фармасютикълс България ЕООД, България Teva Pharma S.L.U., Spain; TEVA Pharmaceutical Works Private Limited Company, Debrecen Hungary; TEVA Pharmaceutical Works Private Limited Company, Gödöllö Hungary; Teva Czech Industries s.r.o., Czech Republic; Pharmachemie B.V., the Netherlands; Teva UK, UK; TEVA Sante, France; Teva Operations Poland; Merckle Gmbh, Germany 2.15 0.43 2.58 7% 0.15 2.3 0.46 2.76 20% 0.43 2.73 0.55 3.28 НСР-2295/13.01.2014 11.02.2014 11.02.2014 Неактивен 964
Atorvastatin 20100640 Avanor, Film coated tablet, 20, mg, Pack: 30 Тева Фармасютикълс България ЕООД, България Teva Pharma S.L.U., Spain; TEVA Pharmaceutical Works Private Limited Company, Debrecen Hungary; TEVA Pharmaceutical Works Private Limited Company, Gödöllö Hungary; Teva Czech Industries s.r.o., Czech Republic; Pharmachemie B.V., the Netherlands; Teva UK, UK; TEVA Sante, France; Teva Operations Poland; Merckle Gmbh, Germany 2.37 0.47 2.84 7% 0.17 2.54 0.51 3.05 20% 0.47 3.01 0.6 3.61 КЦРР-2969/20.03.2013 19.04.2013 19.04.2013 Неактивен 964
Atorvastatin 20100641 Avanor, Film coated tablet, 10, mg, Pack: 30 Тева Фармасютикълс България ЕООД, България Teva Pharma S.L.U., Spain; TEVA Pharmaceutical Works Private Limited Company, Debrecen Hungary; TEVA Pharmaceutical Works Private Limited Company, Gödöllö Hungary; Teva Czech Industries s.r.o., Czech Republic; Pharmachemie B.V., the Netherlands; Teva UK, UK; TEVA Sante, France; Teva Operations Poland; Merckle Gmbh, Germany 2.01 0.4 2.41 7% 0.14 2.15 0.43 2.58 20% 0.4 2.55 0.51 3.06 корекц. HCP-8/09.05.2013 КЦРР-2970/20.03.2013 19.04.2013 19.04.2013 Неактивен 2906
Atorvastatin II-9732/31.05.2010 Avanor, Film coated tablet, 20, mg, Pack: 30 Тева Фармасютикълс България ЕООД, България Teva UK Ltd, UK Pharmachemie B.V. Netherlands TEVA Pharmaceutical Works Private Limited Campany, Hungary, TEVA Sante, France TEVA Czech Industries s.r.f., Czech Republic 11.64 2.33 13.97 6% 0.7 12.34 2.47 14.81 18% 2.1 14.44 2.89 17.33 цената се заличава КЦРР-2552/14.03.2013 КЦ-1767/15.09.2010 26.10.2010 26.10.2010 Заличен 964
Bevacizumab EU/1/04/300/002 Avastin, Concentrate for solution for infusion, 25 mg/ml-16 ml, mg, Pack: 1 Roche Registration GmbH, Германия Roche Pharma AG - Germany 1697.78 339.56 2037.34 4% 10 1707.78 341.56 2049.34 16% 25 1732.78 346.56 2079.34 Промяна на обстоятелствата НСР-15777/25.05.2018. НСР-6422/12.06.2015.; НСР-16248/27.07.2018 11.08.2018 02.09.2018 Активен 3222
Bevacizumab EU/1/04/300/002 Avastin, Concentrate for solution for infusion, 25 mg/ml-16 ml, mg, Pack: 1 Roche Registration GmbH, Германия Roche Pharma AG - Germany 1787.14 357.43 2144.57 4% 10 1797.14 359.43 2156.57 16% 25 1822.14 364.43 2186.57 Промяна на обстоятелствата НСР-15777/25.05.2018. НСР-6422/12.06.2015. 26.06.2015 02.07.2018 Неактивен 3222
Bevacizumab EU/1/04/300/001 Avastin, Concentrate for solution for infusion, 25 mg/ml-4 ml, mg, Pack: 1 Roche Registration GmbH, Германия Roche Pharma AG - Germany 461.36 92.27 553.63 4% 10 471.36 94.27 565.63 16% 25 496.36 99.27 595.63 Промяна на обстоятелствата НСР-15778/25.05.2018. НСР-6421/12.06.2015.; НСР-16246/27.07.2018 11.08.2018 02.09.2018 Активен 3221
Bevacizumab EU/1/04/300/001 Avastin, Concentrate for solution for infusion, 25 mg/ml-4 ml, mg, Pack: 1 Roche Registration GmbH, Германия Roche Pharma AG - Germany 485.65 97.13 582.78 4% 10 495.65 99.13 594.78 16% 25 520.65 104.13 624.78 Промяна на обстоятелствата НСР-15778/25.05.2018. НСР-6421/12.06.2015. 26.06.2015 02.07.2018 Неактивен 3221
Bevacizumab EU/1/04/300/002 Avastin, Concentrate for solution for infusion, 25 mg/ml-16 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG - Germany 1787.14 357.43 2144.57 4% 10 1797.14 359.43 2156.57 16% 25 1822.14 364.43 2186.57 НСР-6422/12.06.2015. 26.06.2015 26.06.2015 Неактивен 3222
Bevacizumab EU/1/04/300/001 Avastin, Concentrate for solution for infusion, 25 mg/ml-4 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG - Germany 485.65 97.13 582.78 4% 10 495.65 99.13 594.78 16% 25 520.65 104.13 624.78 НСР-6421/12.06.2015. 26.06.2015 26.06.2015 Неактивен 3221
Bevacizumab EU/1/04/ 300/002 Avastin, Concentrate for solution for infusion, 25 mg/ml-16 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG - Germany 1787.14 357.43 2144.57 4% 10 1797.14 359.43 2156.57 16% 25 1822.14 364.43 2186.57 НСР-6422/12.06.2015. 26.06.2015 26.06.2015 Неактивен 3222
Bevacizumab EU/1/04/ 300/001 Avastin, Concentrate for solution for infusion, 25 mg/ml-4 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG - Germany 485.65 97.13 582.78 4% 10 495.65 99.13 594.78 16% 25 520.65 104.13 624.78 НСР-6421/12.06.2015. 26.06.2015 26.06.2015 Неактивен 3221
Bevacizumab EU/1/04/ 300/002 Avastin, Concentrate for solution for infusion, 25 mg/ml-16 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG - Germany 1787.14 357.43 2144.57 4% 10 1797.14 359.43 2156.57 16% 25 1822.14 364.43 2186.57 НСР-6422/12.06.2015. 26.06.2015 26.06.2015 Неактивен 3222
Bevacizumab EU/1/04/ 300/001 Avastin, Concentrate for solution for infusion, 25 mg/ml-4 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG - Germany 485.65 97.13 582.78 4% 10 495.65 99.13 594.78 16% 25 520.65 104.13 624.78 НСР-6421/12.06.2015. 26.06.2015 26.06.2015 Неактивен 3221
Bevacizumab EU/1/04/300/002 Avastin, Concentrate for solution for infusion, 25 mg/ml-16 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG - Germany 1921.66 384.33 2305.99 4% 10 1931.66 386.33 2317.99 16% 25 1956.66 391.33 2347.99 НСР-4815/13.10.2014 27.10.2014 27.10.2014 Неактивен 3222
Bevacizumab EU/1/04/300/001 Avastin, Concentrate for solution for infusion, 25 mg/ml-4 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG - Germany 522.21 104.44 626.65 4% 10 532.21 106.44 638.65 16% 25 557.21 111.44 668.65 НСР-4816/13.10.2014 27.10.2014 27.10.2014 Неактивен 3221
Bevacizumab EU/1/04/300/001 Avastin, Concentrate for solution for infusion, 25 mg/ml-4 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG - Germany 543.97 108.79 652.76 4% 10 553.97 110.79 664.76 16% 25 578.97 115.79 694.76 корекц. НСР-2917/07.03.2014 НСР-2317/13.01.2014 14.02.2014 14.02.2014 Неактивен 3221
Bevacizumab EU/1/04/300/002 Avastin, Concentrate for solution for infusion, 25 mg/ml-16 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG - Germany 2001.71 400.34 2402.05 4% 10 2011.71 402.34 2414.05 16% 25 2036.71 407.34 2444.05 корекц. НСР-2917/07.03.2014 НСР-2316/13.01.2014 14.02.2014 14.02.2014 Неактивен 3222
Bevacizumab EU/1/04/300/001 Avastin, Concentrate for solution for infusion, 25 mg/ml-4 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG - Germany 560.5 112.1 672.6 4% 10 570.5 114.1 684.6 16% 25 595.5 119.1 714.6 КЦРР-2732/20.03.2013 18.04.2013 18.04.2013 Неактивен 3221
Bevacizumab EU/1/04/300/002 Avastin, Concentrate for solution for infusion, 25 mg/ml-16 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG - Germany 2129.49 425.9 2555.39 4% 10 2139.49 427.9 2567.39 16% 25 2164.49 432.9 2597.39 КЦРР-2800/20.03.2013 18.04.2013 18.04.2013 Неактивен 3222
Bevacizumab EU/1/04/300/002 Avastin, Concentrate for solution for infusion, 25 mg/ml-16 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG - Germany 2148.93 429.79 2578.72 4% 10 2158.93 431.79 2590.72 16% 25 2183.93 436.79 2620.72 КЦРР-923/04.07.2012 19.07.2012 19.07.2012 Неактивен 3222
Показва 1275 до 1299 от общо 14922 записа
Линк за сваляне в CSV формат: Копирай
Линк за сваляне в JSON формат: Копирай
Линк за сваляне в XML формат: Копирай
 

Моля изчакайте